1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Feasibility of interim PET-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): Sub-analysis of SWOG S0816 phase 2 trial
    Meeting Abstract

    Danilov, A. V.; Li, H. L.; Press, O. W.; Shapira, I.; Swinnen, L. J.; Noy, A.; Reid, E.; Smith, S. M.; Friedberg, J. W.
    Blood (2015)

    Fulltext@MSK | Save
  • Molecular profiling and relationship with clinical response in patients with IDH1 mutation-positive hematologic malignancies receiving AG-120, a first-in-class potent inhibitor of mutant IDH1, in addition to data from the completed dose escalation portion of the phase 1 study
    Meeting Abstract

    DiNardo, C.; de Botton, S.; Pollyea, D. A.; Stein, E. M.; Fathi, A. T.; Roboz, G. J.; Collins, R.; Swords, R. T.; Flinn, I. W.; Altman, J. K.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Risk-adapted therapy in adults with Burkitt lymphoma: Preliminary report of a multicenter prospective phase II study of DA-EPOCH-R
    Meeting Abstract

    Dunleavy, K.; Noy, A.; Abramson, J. S.; LaCasce, A. S.; Link, B. K.; Parekh, S.; Jagadeesh, D.; Bierman, P. J.; Mitsuyasu, R. T.; Battini, R.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Alemtuzumab-cyclosporine versus tacrolimus-methotrexate-sirolimus for graft-versus-host disease prophylaxis in reduced intensity allogeneic hematopoietic stem cell transplantation from unrelated donors: Final results of a randomized trial
    Meeting Abstract

    Curtis, L. M.; Pavletic, S. Z.; Salit, R. B.; Shaffer, B. C.; Steinberg, S. M.; Wilder, J. S.; Pirsl, F.; Blacklock-Schuver, B.; Hsu, J.; Hughes, T. E.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Outcomes of inferior vena cava filter placement in a large population of cancer patients diagnosed with pulmonary embolism: Risk for recurrent venous thromboembolism, survival, and filter-related complications
    Meeting Abstract

    Coombs, C. C.; Kuk, D.; Devlin, S.; Siegelbaum, R.; Parameswaran, R.; Mantha, S.; Soff, G. A.
    Blood (2015)

    Fulltext@MSK | Save
  • PD-1 blockade with pembrolizumab in patients with classical Hodgkin lymphoma after brentuximab vedotin failure: Safety, efficacy, and biomarker assessment
    Meeting Abstract

    Armand, P.; Shipp, M. A.; Ribrag, V.; Michot, J. M.; Zinzani, P. L.; Gutierrez, M.; Snyder, E.; Ricart, A. D.; Balakumaran, A.; Moskowitz, C. H.
    Blood (2015)

    Fulltext@MSK | Save
  • Presence of PD-1 expressing T cells predicts for inferior overall survival in newly diagnosed multiple myeloma
    Meeting Abstract

    Gasmi, B.; Smith, E. L.; Dogan, A.; Hsu, M.; Devlin, S.; Pichardo, J. D.; Chung, D. J.; Koehne, G.; Korde, N. S.; Landau, H. J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Genomic and proteomic analysis of primary chemoresistance and induction failure in acute myeloid leukemia
    Meeting Abstract

    Brown, F.; Still, E.; Cifani, P.; Ficarro, S.; Pouliot, G.; Drill, E.; Gonen, M.; He, J.; Balasubramanian, S.; Zhong, S.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • A chromatin reader that acts as a key to lock in and coordinate recruitment of transcription factors and a novel polycomb complex to bivalent chromatin thus driving formation of germinal centers and B-cell lymphomas
    Meeting Abstract

    Beguelin, W.; Teater, M.; Corcoran, C.; Hamline, M.; Gascoyne, R. D.; Levine, R. L.; Abdel-Wahab, O.; Shaknovich, R.; Elemento, O.; Bardwell, V. J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Predictors of early death in childhood acute promyelocytic leukemia: Results of an international retrospective study
    Meeting Abstract

    Abla, O.; Ribeiro, R. C.; Testi, A. M.; Fernandez, P. M.; Creutzig, U.; Sung, L. L.; Di Giuseppe, G.; Stephens, D.; Hasle, H.; Kaspers, G. J. L.; more...
    Blood (2015)

    Fulltext@MSK | Save